Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- Pharmacosmos today announced the initiation of a phase III, randomised, double- …